No two patients are alike. Recent medical science discoveries show tremendous differences in genomic abnormalities among individual patients with the same disease. These breakthrough findings of genetic heterogeneity and subclonal disease architecture explain why individual patient responses to one-size-fits-all treatment are variable and transient.
The goal of precision medicine is to tailor treatment to the individual patient using the patientâs distinctive disease information. By using patient-specific molecular data, precision medicine empowers health care providers with a more educated understanding of the patient and enables rational design of treatment plans with the best possibility for success.
The medical community now recognizes the potential of precision medicine to transform health care.While physicians are increasingly ordering molecular tests on their patients, less than 1% of the test results are actually used in patient management due to the complexity and large amount of information.
Every health evaluation and medical decision depends upon the quality and thoroughness of examination results. When it comes to managing patients in the post-genomic era, health care providers need help in interpreting the complicated and immense quantity of test results so that the patient-specific information can be used to its fullest potential.
Advances in laboratory technology have lowered the cost and turn-around time of generating large genomic and proteomic datasets from patients. Until recently, it was not possible to clinically interpret these molecular data with respect to the individual. Today we can.
Cellworks uses a specialized technology to create simulation models of diseases like Cancer. Using genomic data of the patient, Cellworks creates a computer-simulated avatar and then uses the personalized avatar to design and test possible therapies. Cellworks precision medicine results are the most detailed insight into the individual patient's disease and potential treatments available anywhere.
Cellworks empowers physicians to fully understand the significance of complex genomic mutations in every patient. With greater understanding comes greater power to heal. This, truly, is personalized therapy.
Our precision medicine platform simulates millions of experiments for a specific patient on a HIPAA-compliant Cloud infrastructure, and helps payers and providers improve quality of care while reducing cost.
Physicians at point of care can make better-informed decisions customized for each patient and potentially identify treatment options where none existed before. With Cellworks, life science companies can develop and test products for the right audience.
Contact us to learn how Cellworks combines the latest advances in genomics with power of the Cloud computing today to give simulated predictions for individual patients.
|Input Formats||NGS - Targeted gene Panel(FoundationOne)||Additional Formats
ACGH (Agilent Microarray / MoGene, GenPath)
NGS - Targeted Gene Panel (NeoGenomics)
|Simulated Drug Agents Library||FDA Approved agents||Additional Phase 3 Clinical Trial Agents|
|Customized Personalization||Reduction of Cancer Growth or Proliferation or Viability||Additional Custom Personalization|